Males (%)* | 403 (57) | 206 (58) | 102 (71) |
Age (y) | 52 (13) | 50 (13) | 53 (12) |
BMI (kg/m2) | 24.2 (4.2) | 24.5 (4.3) | 25.2 (4.3) |
AST (UI/l) | 59.5 (86.1) | 71.3 (110.5) | 94.7 (138.7) |
ALT (UI/l) | 79.2 (108.3) | 82.7 (106.6) | 108.1 (119.1) |
GGT (UI/l) | 136 (245) | 159 (229) | 206 (272) |
Total bilirubin (μmol/l) | 16.9 (31.5) | 19.7 (37.3) | 27.3 (44) |
Platelet count (G/l) | 209 (87) | 213 (91) | 165 (83) |
Prothrombin time (%) | 90 (14) | 89 (15) | 82 (17) |
Factor V (%) | 88.6 (18.5) | 92.5 (15) | 80.5 (20.5) |
Albumin (g/l) | 38.5 (5.6) | 38.5 (5.2) | 36.1 (6.3) |
α Fetoprotein (ng/ml) | 49 (456) | 31 (105) | 54 (270) |
Fibrosis score (%)* | | | |
No or mild fibrosis | | 111 (31) | |
Moderate fibrosis | | 99 (28) | |
Severe fibrosis | | 49 (14) | |
Cirrhosis | | 95 (27) | |
Past history of ascites* | | | 18 (13) |
Past history of bleeding varices* | | | 14 (10) |
Hepatocellular carcinoma* | | | 19 (13) |
Oesophageal varices stage 2/3* | | | 42 (29) |
US splenomegaly* | | | 48 (33) |